Reference
Busetto GM, Porreca A, Del Giudice F, et al. SARS-CoV-2 infection and high-risk non-muscle-invasive bladder cancer: are there any common features. Urol Int. 2020; 104:7-8: 510-522.10.1159/000509065.
Schäfer, G., Blumenthal, M. J., and Katz, A. A. (2015). Interaction of human tumor
viruses with host cell surface receptors and cell entry. Viruses;7, 2: 2592–2617. doi: 10.3390/v7052592.
3. Schaftenaar E, Verjans G, Getu S, McIntyre JA, Struthers HE, Osterhaus ADME., et al. High seroprevalence of human herpesviruses in HIV-infected individuals attending primary healthcare facilities in rural South Africa. Journal one 2004; 9: 9924.
  1. Blumenthal MJ, Lambarey H, Chetram A, riou C, Wilkinson RJ , Schäfer G. Kaposi’s sarcoma-associated Herpesvirus, but not epstein-barr Virus, co-infection associates with coronavirus disease 2019 severity and outcome in south african patients. South Africa: Rosemary Ann Dorrington, 2022.
  2. Manhaz F, Robert AS. Oral Kaposi’s sarcoma: a review and update. Int J Dermatol, 2013 Jun; 52: 666-72.
  3. Francesca Magri F, Giordano S, Latini A, Muscianese M. New-onset cutaneous kaposi’s sarcoma following SARS-CoV-2 infection. J Cosmet Dermatol. 2021; 20: 3747–3750.
  4. Li YS, Ren HC, Cao JH. Correlation of SARS‑CoV‑2 to cancer: Carcinogenic or anticancer? (Review). International journal of oncology 2022. 60: 42.
Acknowledgments: not applicable